Literature DB >> 20346028

Type 1 interferon signature in the scalp lesions of alopecia areata.

M Ghoreishi1, M Martinka, J P Dutz.   

Abstract

BACKGROUND: Autoimmune attack of the bulbar region of anagen phase hair follicles by CD8+ T cells and Th1 cytokines has been proposed to result in hair loss in alopecia areata (AA). The initiating stimuli are unknown. As interferon-alpha therapy may trigger AA, we propose that type 1 interferons are involved in the induction of disease.
OBJECTIVES: To compare lesional scalp from patients with AA with scalp lesions of cutaneous diseases associated with local type 1 interferon-related protein expression.
METHODS: Lesional scalp of patients with AA, discoid lupus erythematosus, lichen planopilaris and androgenetic alopecia was examined by immunohistochemistry for expression of the type 1 interferon-inducible myxovirus protein A (MxA), the chemokine receptor CXCR3, and the cytotoxic proteins granzyme B (GrB) and T-cell intracytoplasmic antigen 1 (TiA-1).
RESULTS: MxA was expressed in the intradermal and subcutaneous compartments of the hair follicle including sebaceous glands in inflammatory AA similar to lesions of cicatricial alopecia (discoid lupus erythematosus, lichen planopilaris) but not in the epidermal compartment of AA, and not at all in noninflammatory AA or androgenetic alopecia. The location of CXCR3-expressing cells correlated with MxA expression. The inflammatory cells around the hair follicle in AA included a lower number of GrB+ and TiA-1+ cells compared with cicatricial alopecia and demonstrated predominant TiA-1+ expression.
CONCLUSIONS: We demonstrate the expression of type 1 interferon-related proteins in the inflammatory lesions of AA. The distribution pattern of the interferon signature and cytotoxicity-associated proteins in AA differs from cicatricial alopecia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20346028     DOI: 10.1111/j.1365-2133.2010.09775.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

1.  Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin.

Authors:  Keisuke Nagao; Tetsuro Kobayashi; Kazuyo Moro; Manabu Ohyama; Takeya Adachi; Daniela Y Kitashima; Satoshi Ueha; Keisuke Horiuchi; Hideaki Tanizaki; Kenji Kabashima; Akiharu Kubo; Young-hun Cho; Björn E Clausen; Kouji Matsushima; Makoto Suematsu; Glaucia C Furtado; Sergio A Lira; Joshua M Farber; Mark C Udey; Masayuki Amagai
Journal:  Nat Immunol       Date:  2012-06-24       Impact factor: 25.606

Review 2.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

Review 3.  JAK Inhibitors for Treatment of Alopecia Areata.

Authors:  Eddy H C Wang; Brigitte N Sallee; Christina I Tejeda; Angela M Christiano
Journal:  J Invest Dermatol       Date:  2018-07-26       Impact factor: 8.551

Review 4.  Alopecia areata.

Authors:  C Herbert Pratt; Lloyd E King; Andrew G Messenger; Angela M Christiano; John P Sundberg
Journal:  Nat Rev Dis Primers       Date:  2017-03-16       Impact factor: 52.329

Review 5.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

Review 6.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

7.  Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.

Authors:  Zhenpeng Dai; James Chen; Yuqian Chang; Angela M Christiano
Journal:  JCI Insight       Date:  2021-04-08

8.  Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse.

Authors:  Caroline G McPhee; F Jason Duncan; Kathleen A Silva; Lloyd E King; Harm Hogenesch; Derry C Roopenian; Helen B Everts; John P Sundberg
Journal:  J Invest Dermatol       Date:  2012-02-23       Impact factor: 8.551

9.  Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.

Authors:  David Wong; Bory Kea; Rob Pesich; Brandon W Higgs; Wei Zhu; Patrick Brown; Yihong Yao; David Fiorentino
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

10.  NLRP3 inflammasome activation contributes to development of alopecia areata in C3H/HeJ mice.

Authors:  Kei Hashimoto; Yoshihito Yamada; Kota Sekiguchi; Sachi Mori; Tatsumi Matsumoto
Journal:  Exp Dermatol       Date:  2021-07-26       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.